Search Results - Norbert Vey

Refine Results
  1. 1

    Predicting outcome of patients with myelodysplastic syndromes after failure of azacitidine: validation of the North American MDS consortium scoring system by Thomas Prebet, Pierre Fenaux, Norbert Vey

    Published in Haematologica (2016-10-01)
    Get full text
    Article


  2. 2

    Multiple cytogenetics forms of KMT2A amplification and jumping translocation in a case of myelodysplastic syndrome by Antoine Ittel, Norbert Vey, Marie‐Joëlle Mozziconacci

    Published in eJHaem (2021-11-01)
    Get full text
    Article


  3. 3

    Current status of reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia by Didier Blaise, Norbert Vey, Catherine Faucher, Mohamad Mohty

    Published in Haematologica (2007-04-01)
    Get full text
    Article


  4. 4

    Outcome of patients with low-risk myelodysplasia after azacitidine treatment failure by Thomas Prébet, Sylvain Thepot, Steven D. Gore, François Dreyfus, Pierre Fenaux, Norbert Vey

    Published in Haematologica (2013-02-01)
    Get full text
    Article


  5. 5

    Anthracycline dose intensification improves molecular response and outcome of patients treated for core binding factor acute myeloid leukemia by Thomas Prebet, Sarah Bertoli, Jacques Delaunay, Arnaud Pigneux, Eric Delabesse, Marie Joelle Mozziconacci, Audrey Bidet, Christian Recher, Norbert Vey

    Published in Haematologica (2014-10-01)
    Get full text
    Article


  6. 6

    P548: PRELIMINARY RESULTS OF A PHASE 1, FIRST-IN-HUMAN STUDY OF INA03, AN ANTI-CD71 ANTIBODY-DRUG CONJUGATE IN PATIENTS WITH RELAPSED OR REFRACTORY (R/R) ACUTE LEUKEMIAS by Sylvain Garciaz, Pierre Bories, Leonor Lopez Almeida, Jean-Marie Boher, Coralie Belanger, Christian Recher, Olivier Hermine, Norbert Vey, Pierre Launay

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  7. 7

    Acute erythroid leukemias have a distinct molecular hierarchy from non-erythroid acute myeloid leukemias by Nathalie Cervera, Anne-Catherine Lhoumeau, José Adélaïde, Arnaud Guille, Anne Murati, Marie-Joëlle Mozziconacci, Norbert Vey, Daniel Birnbaum, Véronique Gelsi-Boyer

    Published in Haematologica (2020-07-01)
    Get full text
    Article


  8. 8

    Erythroleukemia: Classification by Nathalie Cervera, Arnaud Guille, José Adélaïde, Marie‐Anne Hospital, Sylvain Garciaz, Marie‐Joelle Mozziconacci, Norbert Vey, Véronique Gelsi‐Boyer, Daniel Birnbaum

    Published in eJHaem (2023-05-01)
    Get full text
    Article


  9. 9

    Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results by Arnaud Pigneux, Virginie Perreau, Eric Jourdan, Norbert Vey, Nicole Dastugue, Françoise Huguet, Jean-Jacques Sotto, L. Rachid Salmi, Norbert Ifrah, Josy Reiffers

    Published in Haematologica (2007-10-01)
    Get full text
    Article


  10. 10

    316 EVICTION Study: Preliminary results in solid tumor patients with ICT01, a first-in-class, gamma9 delta2 T cell activating antibody targeting butyrophilin-3A by Aurélien Marabelle, Martin Wermke, Aude de Gassart, Daniel Olive, Patrick Brune, Emmanuel Valentin, Paul Frohna, Christiane Jungels, Norbert Vey, Elena Garralda, Marina Iché

    Published in Journal for ImmunoTherapy of Cancer (2020-11-01)
    Article


  11. 11

    Prognostic Immune Effector Signature in Adult Acute Lymphoblastic Leukemia Patients Is Dominated by γδ T Cells by Anne-Charlotte Le Floch, Marie-Sarah Rouvière, Nassim Salem, Amira Ben Amara, Florence Orlanducci, Norbert Vey, Laurent Gorvel, Anne-Sophie Chretien, Daniel Olive

    Published in Cells (2023-06-01)
    Get full text
    Article


  12. 12

    Immunomodulatory Drugs Exert Anti-Leukemia Effects in Acute Myeloid Leukemia by Direct and Immunostimulatory Activities by Aude Le Roy, Aude Le Roy, Thomas Prébet, Rémy Castellano, Armelle Goubard, Florence Riccardi, Florence Riccardi, Cyril Fauriat, Cyril Fauriat, Samuel Granjeaud, Audrey Benyamine, Céline Castanier, Florence Orlanducci, Florence Orlanducci, Amira Ben Amara, Amira Ben Amara, Frédéric Pont, Jean-Jacques Fournié, Yves Collette, Jean-Louis Mege, Norbert Vey, Norbert Vey, Daniel Olive, Daniel Olive

    Published in Frontiers in Immunology (2018-05-01)
    Get full text
    Article


  13. 13

    Tripartite prehabilitation of patients with acute myeloid leukaemia and high-risk myelodysplastic syndromes during intensive chemotherapy before allogeneic haematopoietic stem cell... by Jean-Marie Boher, Norbert Vey, Colombe Saillard, Sarah Cuvelier, Charlène Villaron-Goetgheluck, Leonor Almeida-Lopez, Anne-Gaelle Le Corroller, Pauline Denis, Céline Rivieccio, Sarah Calvin, Cécile Bannier-Braticevic

    Published in BMJ Open (2024-03-01)
    Get full text
    Article


  14. 14

    Genomic analysis of myeloproliferative neoplasms in chronic and acute phases by Frédéric Courtier, Nadine Carbuccia, Séverine Garnier, Arnaud Guille, José Adélaïde, Nathalie Cervera, Véronique Gelsi-Boyer, Marie-Joelle Mozziconacci, Jérôme Rey, Norbert Vey, Max Chaffanet, Daniel Birnbaum, Anne Murati

    Published in Haematologica (2017-01-01)
    Get full text
    Article


  15. 15

    Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase by Mandy Brecqueville, Jérôme Rey, Raynier Devillier, Arnaud Guille, Rémi Gillet, José Adélaide, Véronique Gelsi-Boyer, Christine Arnoulet, Max Chaffanet, Marie-Joelle Mozziconacci, Norbert Vey, Daniel Birnbaum, Anne Murati

    Published in Haematologica (2014-01-01)
    Get full text
    Article


  16. 16

    Fit αβ T-cell receptor suppresses leukemogenesis of Pten-deficient thymocytes by Stéphanie Gon, Marie Loosveld, Thomas Crouzet, Delphine Potier, Mélanie Bonnet, Stéphanie O. Morin, Gérard Michel, Norbert Vey, Jacques A. Nunès, Bernard Malissen, Romain Roncagalli, Bertrand Nadel, Dominique Payet-Bornet

    Published in Haematologica (2018-06-01)
    Get full text
    Article


  17. 17

    Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts by Véronique Gelsi-Boyer, Nathalie Cervera, François Bertucci, Mandy Brecqueville, Pascal Finetti, Anne Murati, Christine Arnoulet, Marie-Joelle Mozziconacci, Ken I. Mills, Nicholas C. P. Cross, Norbert Vey, Daniel Birnbaum

    Published in Haematologica (2013-04-01)
    Get full text
    Article


  18. 18

    Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies by Claire Oudin, Patrice Chevallier, Sabine Furst, Thierry Guillaume, Jean El Cheikh, Jacques Delaunay, Luca Castagna, Catherine Faucher, Angela Granata, Raynier Devillier, Christian Chabannon, Benjamin Esterni, Norbert Vey, Mohamad Mohty, Didier Blaise

    Published in Haematologica (2014-11-01)
    Get full text
    Article


  19. 19

    Risk factors and decision criteria for intensive chemotherapy in older patients with acute myeloid leukemia by Jean-Valère Malfuson, Anne Etienne, Pascal Turlure, Thierry de Revel, Xavier Thomas, Nathalie Contentin, Christine Terré, Sophie Rigaudeau, Dominique Bordessoule, Norbert Vey, Claude Gardin, Hervé Dombret, for the Acute Leukemia French Association (ALFA)

    Published in Haematologica (2008-12-01)
    Get full text
    Article


  20. 20

    Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia by Brian Ball, Rami S. Komrokji, Lionel Adès, Mikkael A. Sekeres, Amy E. DeZern, Lisa Pleyer, Norbert Vey, Antonio Almeida, Ulrich Germing, Thomas Cluzeau, Uwe Platzbecker, Steven D. Gore, Pierre Fenaux, Thomas Prebet

    Published in Blood Advances (2018-08-01)
    Get full text
    Article


Search Tools: